Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation

Archives of Ophthalmology

Volumn 116, Issue 10, 1998, Pages 1351-1357

  Yamada, Jun ^a   Dana, M Reza ^a   Zhu, Su Ning ^a   Alard, Pascale ^b   Stralein, J Wayne ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; LEUKOCYTE MIGRATION INHIBITION; MALE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0031666201     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.10.1351     Document Type: Article

References (38)

1. Williams KA, Roder D, Esterman A, et al. Factors predictive of corneal graft survival: report from the Australian Corneal Graft Registry. Ophthalmology. 1992;99:403-414.
2. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
3. Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB J. 1987;1:199-208.
4. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express la antigens. Nature. 1979;282:326-327.
5. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
6. Festenstein H, Doyle P, Holmes J. Long-term follow-up in London Transplant Group recipients of cadaver renal allografts: the influence of HLA matching on transplant outcome. N Engl J Med. 1986;314:7-14.
7. Niederkorn JY. Effect of cytokine-induced migration of Langerhans cells on corneal allografl survival. Eye. 1995;9:215-218.
8. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982;89:700-711.
9. Treseler PA, Foulks GN, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984;98:763-772.
10. Wang HM, Kaplan HJ, Chan WC, Johnson M. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987;28:1383-1389.
11. Rodrigues MM, Rowden G, Hackett J, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci. 1981;21:759-765.
12. Dana MR, Yamada J, Streilein JW. Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997;63:1501-1507.
13. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci. 1995;36:2176-2185.
14. Yamada J, Streilein JW. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber. Invest Ophthalmol Vis Sci. 1997;38:2833-2843.
15. Alard P, Matriano JA, Socarras S, Ortega MA, Streilein JW. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice: microchimerism fails to predict tolerance. Transplantation. 1995;60:1125-1130.
16. Gillette TE, Chandler JW. Immunofluorescence and histochemistry of corneal epithelial flat mounts: use of EDTA. Curr Eye Res. 1981;1:249-253.
17. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987;56:234-248.
18. Dinarello CA, Wolft SM. The role of interleukin 1 in disease. N Engl J Med. 1993;328:106-113.
19. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of participate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol. 1989;2:83-90.
20. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990;348:550-552.
21. Dana MR, Dai R, Zhu S, Yamada J, Streilein JW. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest Ophthalmol Vis Sci. 1998;39:70-77.
22. Benson JL, Niederkorn JY. Interleukin-1 abrogates anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 1990;31:2123-2128.
23. Staats HF, Lausch RM. Cytokine expression in vivo during murine herpetic stromal keratitis: effect of protective antibody therapy. J Immunol. 1993;151:277-283.
24. Kennedy MC, Rosenbaum JT, Brown J, et al. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest. 1995;95:82-88.
25. + Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J Immunol. 1986;136:4362-4371.
26. Niederkorn JY, Mayhew E. "Subthreshold stimulation" of allospecific delayed hypersensitivity by corneal allografts. Immunology. 1993;80:605-610.
27. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-424.
28. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1983;1:143-173.
29. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today. 1994;15:32-38.
30. + T-cell dependent antibody-mediated graft rejection. Immunol Today. 1992;13:434-438.
31. Sayegh MH. Watschinger B, Carpenter CB. Mechanisms of T-cell recognition of alloantigen: the role of peptides. Transplantation. 1994;57:1295-1302.
32. Gebhardt BM. The role of class II antigen-expressing cells in corneal allograft immunity. Invest Ophthalmol Vis Sci. 1990;31:2254-2260.
33. Sano Y, Ksander BR, Streilein JW. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol. 1996;4:53-56.
34. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci. 1997;38:1130-1138.
35. Via CS, Tsokos GC, Stocks NI, Clerici M, Shearer GM. Human in vitro allogeneic responses: demonstration of three pathways of T helper cell activation. J Immunol. 1990;144:2524-2528.
36. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T-cell alloreactivity. J Exp Med. 1993;177:1643-1650.
37. He Y, Mellon J, Apte R, Niederkorn JY. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest Ophthalmol Vis Sci. 1994;35:3218-3225.
38. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.